期刊文献+

线粒体通透性转换孔在冠脉微循环障碍中的研究进展 被引量:1

Research Progress of Mitochondrial Permeability Transition Pore in the Coronary Artery Microcirculation Disturbance
原文传递
导出
摘要 由于冠脉微循环障碍的发生机制比较复杂,临床上治疗冠脉微循环的药物疗效均未得到充分肯定,线粒体通透性转换孔(mitochondrial permeability transition pore,m PTP)的开放因会引起冠脉微循环细胞功能异常而成为当前治疗冠脉微循环障碍的热点研究靶标。本文就近几年国内外关于m PTP在冠脉微循环障碍中的作用研究进展进行简要讨论。 Due to the mechanism of coronary artery microcirculation disturbance is complicated, the drug efficacy of clinical treatment of coronary microcirculation has not been fully affirmed. The open of mitochondrial permeability transition pore(m PTP) which causes coronary microcirculation dysfunction of cells become the hotspot research targets for the treatment of coronary microcirculation dysfunction. In this review, the lastest research progress of m PTP in the coronary artery microcirculation disturbance is briefly discussed.
出处 《中国现代应用药学》 CAS CSCD 2016年第8期1092-1096,共5页 Chinese Journal of Modern Applied Pharmacy
基金 冠心病微血管病变研究基金项目(LSG1501132)
关键词 冠脉微循环障碍 细胞机制 线粒体通透性转换孔 coronary artery microcirculation disturbance cellular mechanism mitochondrial permeability transition pore
  • 相关文献

参考文献41

  • 1LIKOFF W, SEGAL B L, KASPARIAN H. Paradox of normalselective coronary arteriograms in patients considered to haveunmistakble coronary heart disease [J].N Engl J Med, 1967,276(19): 1063-1066.
  • 2JAFFE R, DICK A, STRAUSS B H. Prevention and treatmentof microvascular obstruction-related myocardial injury andcoronary no-reflow following percutaneous coronaryintervention [J], JACC Cardiovasc Interv, 2010, 3(7): 695-704.
  • 3HERRMANN J,KASKI J C, LERMAN A. Coronarymicrovascular dysfunction in the clinical setting: from mysteryto reality [J].Eur Heart J, 2012,33(22): 2771-2781.
  • 4PATEL B, FISHER M. Therapeutic advances in myocardialmicrovascular resistance: unravelling the enigma [J].Pharmacol Ther, 2010, 127(2): 131-147.
  • 5HEUSCH G, BOENGLER K, SCHULZ R. Cardioprotection:nitric oxide, protein kinases, and mitochondria [J].Circuiation,2008,118(19): 1915-1919.
  • 6VEAS C, JARA C, WILLIS N D, et al. Overexpression ofLOXIN protects endothelial progenitor cells from apoptosisinduced by oxidized low density lipoprotein [J].J CardiovascPharmacol, 2016,67(4): 326-335.
  • 7季亢挺,胡建坚,陈军,林加锋,杨鹏麟,唐疾飞.黄芪甲苷对氧化低密度脂蛋白诱导内皮祖细胞炎症损伤的保护作用[J].中国现代应用药学,2013,30(8):827-832. 被引量:12
  • 8RADHIKA A, SUDHAKARAN P R. Upregulation ofmacrophage-specific functions by oxidized LDL: lysosomaldegradation-dependent and -independent pathways [J].MolCell Biochem, 2013, 372(1/2): 181-190.
  • 9CHERIYAN J, WEBB A J, SAROV-BLAT L, et al. Inhibitionof p38 mitogen-activated protein kinase improves nitricoxide-mediated vasodilatation and reduces inflammation inhypercholesterolemia [J].Circulation, 2011, 123(5): 515-523.
  • 10KAPOPARA P R, VON FELDEN J, SOEHNLEIN 0,et al.Deficiency of MAPK-activated protein kinase 2 (MK2)prevents adverse remodelling and promotes endothelial healingafter arterial injury [J], Thromb Haemost, 2014, 112(6):1264-1276.

二级参考文献13

  • 1朱军慧,陈君柱,王兴祥,朱建华,尚云鹏,郭晓纲,戴禾敏.氧化低密度脂蛋白对外周血内皮祖细胞数量和功能的影响[J].中华内分泌代谢杂志,2005,21(1):13-17. 被引量:13
  • 2季亢挺,张怀勤,唐疾飞,李海鹰.丹参对高胆固醇血症患者内皮祖细胞数量及功能的影响[J].中国中药杂志,2007,32(12):1214-1217. 被引量:31
  • 3WERNER N, JUNK S, LAUFS U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury [J]. Circ Res, 2003, 93(2): e 17-e24.
  • 4YAMAHARA K, ITOH H. Potential use of endothelial progenitor cells for regeneration of the vasculature [J]. Ther Adv Cardiovasc Dis, 2009, 3(1): 17-27.
  • 5WANG L X, XING G H, ZHANG J, et al. Effect of astragalus injection on platelet activation in old patients with coronary heart disease [J]. 实用医药杂志,2006,23(3):338-339.
  • 6HILL J M, ZALOS G, HALCOX J P, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [J]. N Engl J Med, 2003, 348(7): 593-600.
  • 7POVSIC T J, GOLDSCHMIDT-CLERMONT P J. Endothelial progenitor cells: markers of vascular reparative capacity [J]. Ther Adv Cardiovasc Dis, 2008, 2(3): 199-213.
  • 8SEN S, MCDONALD S P, COATES P T, et al. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease [J]. Clin Sci(Lond), 2011, 120(7): 263-283.
  • 9GIANNOTTI G, DOERRIES C, MOCHARLA P S, et al. Impaired endothelial repair capacity of early endothelial progenitor ceils in prehypertension: relation to endothelial dysfunction [J]. Hypertension, 2010, 55(6): 1389-1397.
  • 10FU F, CHEN H C, WANG D S. Effect of astragalus injection on hemorheology and blood lipid in patients with coronary heart disease [J]. 现代中西医结合杂志,2006,15(2):165-166.

共引文献11

同被引文献3

引证文献1

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部